Chen Jun, Yang Yueying, Gao Yunfei, Chu Jianhu, Hou Zhaozhen, Luo Dongbo
Department of Thoracic Surgery II, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, Xinjiang, 830011, China.
Department of Thoracic Surgery, People's Hospital of Bayin Guoleng Mongol Autonomous Prefecture, Korla, Xinjiang, 841000, China.
World J Surg Oncol. 2025 Jun 9;23(1):224. doi: 10.1186/s12957-025-03881-4.
To compare the short-term outcomes of multi-arm uniportal robotic-assisted thoracoscopic surgery (URATS) and multiport robotic-assisted thoracoscopic surgery (MRATS) and to evaluate the safety and feasibility of URATS.
A retrospective analysis was conducted on clinical data from patients who underwent robotic-assisted thoracoscopic surgery in the Department of Thoracic Surgery II at Xinjiang Tumor Hospital between May 2023 and January 2025. Patients were categorized into the URATS and MRATS groups based on the surgical approach. A 1:1 propensity score matching (PSM) analysis was performed according to the clinical characteristics of the patients, and the short-term outcomes were compared between the two groups.
A total of 353 patients were included in this study, comprising 153 patients in the URATS group and 200 patients in the MRATS group. After PSM, each group consisted of 115 patients. The intraoperative blood loss in the URATS group was significantly lower than that in the MRATS group [median blood loss: 50 (30,100) mL vs. 100 (50,100) mL; P < 0.001]. The incidence of postoperative complications was lower in the URATS group compared to the MRATS group (5.2% vs. 10.4%, P = 0.041). The median duration of chest tube drainage was longer in the URATS group than in the MRATS group [4 (3,5) days vs. 3 (3,4) days, P = 0.003], and the median postoperative hospital stay was also slightly longer in the URATS group than in the MRATS group [5 (4,6) days vs. 4 (4,5) days, P = 0.037]. No significant differences were observed between the two groups in other perioperative parameters (P > 0.05).
For pulmonary resection and mediastinal tumor resection, URATS demonstrates perioperative outcomes comparable to those of MRATS, with favorable safety and feasibility. URATS not only minimizes access-related surgical trauma but also results in a lower incidence of postoperative complications. Furthermore, it offers superior postoperative cosmetic outcomes, making it a promising technique for clinical application.
比较多臂单孔机器人辅助胸腔镜手术(URATS)与多孔机器人辅助胸腔镜手术(MRATS)的短期疗效,并评估URATS的安全性和可行性。
对2023年5月至2025年1月在新疆肿瘤医院胸外科二病区接受机器人辅助胸腔镜手术的患者临床资料进行回顾性分析。根据手术方式将患者分为URATS组和MRATS组。根据患者的临床特征进行1:1倾向评分匹配(PSM)分析,比较两组的短期疗效。
本研究共纳入353例患者,其中URATS组153例,MRATS组200例。PSM后,每组各有115例患者。URATS组术中出血量明显低于MRATS组[中位出血量:50(30,100)mL对100(50,100)mL;P<0.001]。URATS组术后并发症发生率低于MRATS组(5.2%对10.4%,P=0.041)。URATS组胸腔闭式引流中位时间长于MRATS组[4(3,5)天对3(3,4)天,P=0.003],URATS组术后中位住院时间也略长于MRATS组[5(4,6)天对4(4,5)天,P=0.037]。两组其他围手术期参数差异无统计学意义(P>0.05)。
对于肺切除和纵隔肿瘤切除,URATS的围手术期疗效与MRATS相当,安全性和可行性良好。URATS不仅能将与手术入路相关的创伤降至最低,还能降低术后并发症的发生率。此外,它还具有更好的术后美容效果,是一种很有临床应用前景的技术。